| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.03 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.03 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.04 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |